Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changwei Lin

Showing results (41-50 of 95) with videos related to

Pageof 10
Sort By:
Molecular Medicine Reports|July 8, 2015
Combinational treatment with microRNA‑133b and cetuximab has increased inhibitory effects on the growth and invasion of colorectal cancer cells by regulating EGFRJianyu Zhou, Lv Lv, Changwei Lin, et al.
Cancer Cell International|March 28, 2018
Long noncoding RNA LINC01510 promotes the growth of colorectal cancer cells by modulating MET expressionChaoqun Cen, Jian Li, Jingjing Liu, et al.
Molecular Cancer|February 4, 2021
Comprehensive landscape and future perspectives of circular RNAs in colorectal cancerFei Long, Zhi Lin, Liang Li, et al.
Oncology Letters|August 24, 2023
Erratum: [Corrigendum] DNA methylation is involved in the aberrant expression of miR‑133b in colorectal cancer cellsLv Lv, Jianyu Zhou, Changwei Lin, et al.
Oncotarget|April 20, 2017
miR-133b, a particular member of myomiRs, coming into playing its unique pathological role in human cancerDaojiang Li, Lu Xia, Miao Chen, et al.
Oncology Reports|December 12, 2018
Overexpressed PLAGL2 transcriptionally activates Wnt6 and promotes cancer development in colorectal cancerNanpeng Li, Daojiang Li, Yuheng Du, et al.
International Journal of Clinical and Experimental Pathology|August 12, 2015
Effect of antisense microRNA targeting survivin on rectal cancer HRC-9698 cells and its mechanismJing Dai, Wei Wu, Jianyu Zhou, et al.
Oncotarget|November 29, 2016
Negative feedback between TAp63 and Mir-133b mediates colorectal cancer suppressionJing Dai, Hao Wu, Yi Zhang, et al.
Frontiers in Oncology|June 13, 2022
Identification and Validation of Novel Immune-Related Alternative Splicing Signatures as a Prognostic Model for Colon CancerYunze Liu, Lei Xu, Chuanchuan Hao, et al.
International Journal of Oncology|March 8, 2018
Studying the mechanism of PLAGL2 overexpression and its carcinogenic characteristics based on 3'-untranslated region in colorectal cancerChen Su, Daojiang Li, Nanpeng Li, et al.
Pageof 10

Showing results (41-50 of 95) with videos related to

Sort By:
Pageof 10
Molecular Medicine Reports|July 8, 2015
Combinational treatment with microRNA‑133b and cetuximab has increased inhibitory effects on the growth and invasion of colorectal cancer cells by regulating EGFRJianyu Zhou, Lv Lv, Changwei Lin, et al.
Cancer Cell International|March 28, 2018
Long noncoding RNA LINC01510 promotes the growth of colorectal cancer cells by modulating MET expressionChaoqun Cen, Jian Li, Jingjing Liu, et al.
Molecular Cancer|February 4, 2021
Comprehensive landscape and future perspectives of circular RNAs in colorectal cancerFei Long, Zhi Lin, Liang Li, et al.
Oncology Letters|August 24, 2023
Erratum: [Corrigendum] DNA methylation is involved in the aberrant expression of miR‑133b in colorectal cancer cellsLv Lv, Jianyu Zhou, Changwei Lin, et al.
Oncotarget|April 20, 2017
miR-133b, a particular member of myomiRs, coming into playing its unique pathological role in human cancerDaojiang Li, Lu Xia, Miao Chen, et al.
Oncology Reports|December 12, 2018
Overexpressed PLAGL2 transcriptionally activates Wnt6 and promotes cancer development in colorectal cancerNanpeng Li, Daojiang Li, Yuheng Du, et al.
International Journal of Clinical and Experimental Pathology|August 12, 2015
Effect of antisense microRNA targeting survivin on rectal cancer HRC-9698 cells and its mechanismJing Dai, Wei Wu, Jianyu Zhou, et al.
Oncotarget|November 29, 2016
Negative feedback between TAp63 and Mir-133b mediates colorectal cancer suppressionJing Dai, Hao Wu, Yi Zhang, et al.
Frontiers in Oncology|June 13, 2022
Identification and Validation of Novel Immune-Related Alternative Splicing Signatures as a Prognostic Model for Colon CancerYunze Liu, Lei Xu, Chuanchuan Hao, et al.
International Journal of Oncology|March 8, 2018
Studying the mechanism of PLAGL2 overexpression and its carcinogenic characteristics based on 3'-untranslated region in colorectal cancerChen Su, Daojiang Li, Nanpeng Li, et al.
Pageof 10